| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/04/2014 | US8663912 Fluorogenic substrate for ADAMTS13 |
| 03/04/2014 | US8663711 Use of armillaridin for treating cancer |
| 03/04/2014 | US8663703 Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them |
| 03/04/2014 | US8663696 Film delivery system for tetrahydrolipstatin |
| 03/04/2014 | US8663679 Compositions for improving breast health in women |
| 03/04/2014 | US8663677 Controlled release system and manufacturing method thereof |
| 03/04/2014 | US8663675 Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction |
| 03/04/2014 | US8663674 Microparticle containing matrices for drug delivery |
| 03/04/2014 | US8663652 Regeneration of endogenous myocardial tissue |
| 03/04/2014 | US8663651 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation |
| 03/04/2014 | US8663648 Agents for treatment of HCV and methods of use |
| 03/04/2014 | US8663646 P53 peptide vaccine |
| 03/04/2014 | US8663645 Use of native peptides and their optimized derivatives for vaccination |
| 03/04/2014 | US8663633 Protease screening methods and proteases identified thereby |
| 03/04/2014 | US8663632 Compositions and methods for selectively targeting cancer cells using a thiaminase compound |
| 03/04/2014 | US8663631 Methods for treating lysosomal acid lipase deficiency in patients |
| 03/04/2014 | US8663630 Promotion of peroxisomal catalase function in cells |
| 03/04/2014 | US8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereof |
| 03/04/2014 | US8663628 Solid phase glycerolysis |
| 03/04/2014 | US8663155 Transdermal drug delivery devices having coated microprotrusions |
| 03/04/2014 | CA2526490C Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 03/04/2014 | CA2278854C Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes |
| 02/27/2014 | WO2014031982A2 Methods and compositions for treating pain |
| 02/27/2014 | WO2014031883A1 Neurotherapeutic nanoparticle compositions and devices |
| 02/27/2014 | WO2014031809A1 A neurotoxin for treating premature ejaculation |
| 02/27/2014 | WO2014031656A1 Antibodies to olanzapine haptens and use thereof |
| 02/27/2014 | WO2014031420A1 Homodimeric proteins |
| 02/27/2014 | WO2014031165A1 Compounds and methods of treating diabetes |
| 02/27/2014 | WO2014030977A1 Pharmaceutical composition comprising, as active ingredients, peptides which exhibit inhibitory activity against angiotensin-i converting enzyme for preventing or treating cardiovascular diseases |
| 02/27/2014 | WO2014030950A1 Oyster hydrolysate-derived novel peptides having effects of inhibiting activity of collagenase, and use thereof |
| 02/27/2014 | WO2014030898A1 Peptides having nf-κb inhibitory activity, or composition comprising same |
| 02/27/2014 | WO2014030801A1 Novel anti-fungal peptide pg-2 derived from gogu valley potato, and use thereof |
| 02/27/2014 | WO2014030708A1 Preparation for preventing or treating type i diabetes |
| 02/27/2014 | WO2014030597A1 Novel compound and method for producing same, novel microorganism, pharmaceutical composition, and anti-tumor agent |
| 02/27/2014 | WO2014030514A1 Muscle atrophy inhibitor |
| 02/27/2014 | WO2014030165A1 Transgenic microalgae and use thereof for oral delivery of proteins |
| 02/27/2014 | WO2014030147A2 Synthetic proteins based on dendrimers |
| 02/27/2014 | WO2014030125A2 Use of a casein hydrolysate as an antiherpetic agent |
| 02/27/2014 | WO2014029924A1 Novel uses of lactoferrin and pharmaceutical and nutraceutical compositions |
| 02/27/2014 | WO2014029022A1 Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitors |
| 02/27/2014 | WO2014028997A1 Synthetic pntx(19) peptide, pharmaceutical compositions and use |
| 02/27/2014 | WO2014005019A3 Cells for producing recombinant iduronate-2-sulfatase |
| 02/27/2014 | WO2014005014A3 Purification of iduronate-2-sulfatase |
| 02/27/2014 | WO2014003538A8 Rapid specific pathogen free animal |
| 02/27/2014 | WO2013190520A3 Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| 02/27/2014 | WO2013178788A3 Manufacture of degarelix |
| 02/27/2014 | WO2013153236A3 Cosmetic composition comprising a muconopeptide |
| 02/27/2014 | WO2013102047A8 Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers |
| 02/27/2014 | WO2013009539A8 Engineered polypeptides having enhanced duration of action and reduced immunogenicity |
| 02/27/2014 | WO2012138774A3 Methods of improving vaccine immunogenicity |
| 02/27/2014 | US20140057974 Methods for therapy of neurodegenerative disease of the brain |
| 02/27/2014 | US20140057923 Treating Sexual Desire Disorders with Flibanserin |
| 02/27/2014 | US20140057856 Compositions and Methods For Enhancing Sialic Acid Levels In Tissue |
| 02/27/2014 | US20140057855 Cyclosporin compositions |
| 02/27/2014 | US20140057854 Topical formulations and uses thereof |
| 02/27/2014 | US20140057852 Treatment of Cancers with A-8R Peptide |
| 02/27/2014 | US20140057851 Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma |
| 02/27/2014 | US20140057849 Wild-type apolipoprotein l-i for use in the prevention of kidney diseases |
| 02/27/2014 | US20140057847 Cardioprotective effects of ghrh agonists |
| 02/27/2014 | US20140057846 Products and methods using soy peptides to lower total and ldl cholesterol levels |
| 02/27/2014 | US20140057845 Composition for treating, improving, or preventing pain |
| 02/27/2014 | US20140057844 Chemical entities and therapeutic uses thereof |
| 02/27/2014 | US20140057843 Compositions for dietary health management |
| 02/27/2014 | US20140057842 Compositions and methods for cell homing and adipogenesis |
| 02/27/2014 | US20140057840 Anti-androgenic agent, sebum secretion blocker, hair growth stimulant, and food or beverage |
| 02/27/2014 | US20140057839 Formulations and methods for weight loss and body contouring |
| 02/27/2014 | US20140057838 Osteoblast-expressed lipocalin 2 regulates glucose metabolism |
| 02/27/2014 | US20140057837 Methods and compositions for the "browning" of white fat |
| 02/27/2014 | US20140057836 Hcv ns3 protease inhibitors |
| 02/27/2014 | US20140057835 Methods for treating hcv |
| 02/27/2014 | US20140057834 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 02/27/2014 | US20140057832 Use of relaxin to increase arterial compliance |
| 02/27/2014 | US20140057337 System and method for electroporating a sample |
| 02/27/2014 | US20140057249 Jak/stat inhibitors and mapk/erk inhibitors for rsv infection |
| 02/27/2014 | US20140057001 Methods of decreasing sebum production in the skin |
| 02/27/2014 | US20140056989 Viral inactivated platelet extract, use and preparation thereof |
| 02/27/2014 | US20140056986 Methods of treating bladder cancer |
| 02/27/2014 | US20140056969 Compositions and methods for sirna inhibition of angiogenesis |
| 02/27/2014 | US20140056964 Granzyme b inhibitor compositions, methods and uses for promoting wound healing |
| 02/27/2014 | US20140056960 Methods for Improving Fracture Healing and Bone Formation |
| 02/27/2014 | US20140056953 Fatty acid acylated amino acids for oral peptide delivery |
| 02/27/2014 | US20140056950 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production |
| 02/27/2014 | US20140056945 Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity |
| 02/27/2014 | US20140056931 Genetic adjuvants for immunotherapy |
| 02/27/2014 | US20140056925 Methods of Reducing Myocardial Injury Following Myocardial Infarction |
| 02/27/2014 | US20140056922 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 02/27/2014 | US20140056921 Hepatocyte Growth Factor Receptor Antagonists and Uses Thereof |
| 02/27/2014 | US20140056919 Methods and compositions for treating inflammatory conditions |
| 02/27/2014 | US20140056911 Breast Endothelial Cell Expression Patterns |
| 02/27/2014 | US20140056900 Method for inhibiting binding to b-cell receptor |
| 02/27/2014 | US20140056892 VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders |
| 02/27/2014 | US20140056891 Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins |
| 02/27/2014 | US20140056887 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/27/2014 | US20140056872 Antagonists of neuropilin receptor function and use thereof |
| 02/27/2014 | US20140056870 Fusion proteins |
| 02/27/2014 | US20140056869 Compositions and Methods for Enhancing Metal Ion Dependent Drug Therapies |
| 02/27/2014 | US20140056867 Targeted therapeutic proteins |
| 02/27/2014 | US20140056847 Inhibitors of serine proteases |
| 02/27/2014 | US20140056846 Treating Hepatitis C Virus Infection |
| 02/27/2014 | US20140056845 Method for Generating Potent Dendritic Cells |